This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Phil Gunby

Arch Intern Med. 1981;141(12):1575.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

A well-known two-phase method of inducing experimental skin tumors in mice involves application of a single dose of an "initiator" carcinogen, which probably triggers cell mutation, followed by repeated applications of a weak or totally noncarcinogenic "promoter."

But now investigators at the Oak Ridge (Tenn) National Laboratory and Michigan State University, East Lansing, say there is more to the process than that—with perhaps three stages in the promotion phase alone— and that this information may shed light on some possible tumor promoters in humans, and how to inhibit them.

Thomas J. Slaga, PhD, of the Oak Ridge facility, told an American Cancer Society seminar in Daytona Beach, Fla, that the first stage of the promotion phase seems to involve induction of primitive stem (embryonic phenotype) cells.

This is followed by morphological and biochemical changes in the skin during the second stage, he said, and then by epidermal hyperplasia during what . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?